Ultram and Weakness - a phase IV clinical study of FDA data
Summary:
Weakness is reported as a side effect among people who take Ultram (tramadol hydrochloride), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Neurontin, and have High blood pressure.
The phase IV clinical study analyzes which people have Weakness when taking Ultram. It is created by eHealthMe based on reports of 26,802 people who have side effects when taking Ultram from the FDA, and is updated regularly.
What is Ultram?
Ultram has active ingredients of tramadol hydrochloride. It is often used in pain. eHealthMe is studying from 28,425 Ultram users. Check the latest studies of Ultram.
What is Weakness?
Weakness is found to be associated with 3,641 drugs and 6,615 conditions by eHealthMe. Check the latest studies of Weakness.
26,802 people reported to have side effects when taking Ultram.
Among them, 1,761 people (6.57%) have Weakness.
Among these 1,761 people:
How long have people been on Ultram when they have Weakness? *
What is the gender of people who have Weakness when taking Ultram? *
What is the age of people who have Weakness when taking Ultram? *
What are other drugs people take besides Ultram? *
What are other side effects people have besides Weakness? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Ultram and have Weakness?
- Check whether Weakness is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Ultram:
- Ultram (28,425 reports)
Weakness treatments and more:
- Weakness (586,876 reports)
How severe was Weakness and when was it recovered:
Expand to all the drugs that have ingredients of tramadol hydrochloride:
- Weakness and drugs with ingredients of tramadol hydrochloride (10,807 reports)
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Ultram:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Weakness:
- Weakness (3,641 drugs)
Browse all the conditions that are associated with Weakness:
- Weakness (6,615 conditions)
Related publications that referenced our studies
- Mansour HM, "Tramadol and Disseminated Intravascular Coagulopathy: A Case Report", Medicine Science, 2015 Jan .
- Mansour HM, "Tramadol and Disseminated Intravascular Coagulopathy: A Case Report", Medicine Science, 2015 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on tramadol hydrochloride (the active ingredients of Ultram) and Ultram (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Memory Loss in Acticlate, how severe and when it was recovered? - now
- Cardiac Disorder and drugs of ingredients of temozolomide - a second ago
- Could Valacyclovir Hydrochloride cause Cardiac Failure? - 2 seconds ago
- Constipation in Imvexxy, how severe and when it was recovered? - 5 seconds ago
- Cytomegalovirus Infection and drugs of ingredients of ramipril - 8 seconds ago
- Could Alendronic Acid cause Abdominal Sepsis? - 10 seconds ago
- Consciousness - Decreased and drugs of ingredients of abacavir sulfate - 14 seconds ago
- Systemic Candida and drugs of ingredients of metronidazole - 22 seconds ago
- Dry Eyes and Blood Creatine Phosphokinase Increased - 25 seconds ago
- Sustiva and Lamivudine drug interactions for women aged 40-49 - 29 seconds ago